NATCOPHARM.NS NATCO Pharma Limited Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
14:27
Nov 13
Nov 13
r/IndianStockMarket
Holding NATCO through weak quarter on guidance, cash
The author is holding 46 NATCO Pharma shares at an average of ₹893 despite a 60.8% YoY net profit decline to ₹202.6 Cr and ~30% revenue drop in Q2 FY27. The bull case rests on management's upgraded FY27 PAT guidance of ₹775–800 Cr, a 28.4% sequential revenue recovery, a debt-free balance sheet with ₹2,250 Cr net cash, and new US product launches as future growth drivers. The author frames the current weakness as a temporary slowdown and intends to hold through it, with the main risk being continued YoY earnings deterioration.
NATCOPHARM.NS
NATCO Pharma Limited
Long
Position: Holding
—
About NATCOPHARM.NS Investor Commentary
Across the available history and selected sources, Buzzberg tracks NATCOPHARM.NS (NATCO Pharma Limited) across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Past 7 days, before deduplication: 1 bullish. Latest voices: u/8_bit_thuglife.